Carazolol

Carazolol is a β1/β2 adrenoceptor antagonist of high potency used in the research of hypertension. Carazolol is also a potent, selective β3-adrenoceptor agonist[1].

Product Specifications

CAS Number

[57775-29-8]

Product Name Alternative

(±) -Carazolol; DL-Carazolol; Suacron

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Adrenergic Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/carazolol.html

Concentration

10mM

Purity

99.71

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

CC(C)NCC(O)COC1=CC=CC2=C1C3=CC=CC=C3N2

Molecular Formula

C18H22N2O2

Molecular Weight

298.39

Precautions

H302, H315, H319, H335

References & Citations

[1]A Méjean, et al. Carazolol: a potent, selective beta 3-adrenoceptor agonist. Eur J Pharmacol. 1995 Nov 30;291 (3) :359-66. |[2]Remzi Gonul, et al. Effects of carazolol on electrocadiographic and trace element status in sheeps. Insights Vet Sci. 2018; 2: 001- 004.